However, the genes that are the target of SOX21-AS1 repressive activity may be contest-specific, since in human colon cancers the lncRNA affects cancer progression and prognosis through epigenetic silencing of a different Cip/Kip inhibitor, p21Cip1/Waf1. The gene discussed is CDKN1A; the disease is malignant colon neoplasm.